U.S. markets closed

Allogene Therapeutics, Inc. (ALLO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
27.50+0.56 (+2.08%)
At close: 4:00PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts15151515
Avg. Estimate-0.54-0.57-1.98-2.61
Low Estimate-0.59-0.62-2.19-3.25
High Estimate-0.5-0.52-1.82-2.25
Year Ago EPS-0.53-0.52-2.08-1.98
Revenue EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts14141515
Avg. Estimate260k10k38.56M30k
Low EstimateN/AN/A38MN/A
High Estimate1.7M200k40.04M500k
Year Ago SalesN/AN/AN/A38.56M
Sales Growth (year/est)N/AN/AN/A-99.90%
Earnings History6/29/20209/29/202012/30/20203/30/2021
EPS Est.-0.54-0.54-0.56-0.46
EPS Actual-0.53-0.52-0.53-0.25
Difference0.010.020.030.21
Surprise %1.90%3.70%5.40%45.70%
EPS TrendCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.54-0.57-1.98-2.61
7 Days Ago-0.54-0.57-2-2.62
30 Days Ago-0.55-0.57-2.18-2.6
60 Days Ago-0.55-0.57-2.19-2.61
90 Days Ago-0.6-0.63-2.45-2.76
EPS RevisionsCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/A1N/A
Up Last 30 Days98129
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days11N/AN/A
Growth EstimatesALLOIndustrySector(s)S&P 500
Current Qtr.-1.90%N/AN/AN/A
Next Qtr.-9.60%N/AN/AN/A
Current Year4.80%N/AN/AN/A
Next Year-31.80%N/AN/AN/A
Next 5 Years (per annum)1.00%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A